Eagle Pharmaceuticals Inc (EGRX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Scott L. Tarriff
Employees:
96
50 TICE BOULEVARD, SUITE 315, WOODCLIFF LAKE, NJ 07677
201-326-5300

Eagle Pharmaceuticals, Inc. is a pharmaceutical company engages in the provision of injectable products. Its activities include development and commercialization of pharmaceutical products for the treatment of areas such as critical care, orphan diseases, and oncology. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.

Data derived from most recent annual or quarterly report
Market Cap 629.971 Million Shares Outstanding13.097 Million Avg 30-day Volume 68.67 Thousand
P/E Ratio37.7807 Dividend Yield0.0 EPS1.37
Price to Revenue2.9805 Debt to Equity0.1636 EBITDA34.101 Million
Price to Book Value2.8549 Operating Margin13.738700000000001 Enterprise Value471.54 Million
Current Ratio3.907 EPS Growth4.833 Quick Ratio3.576
1 Yr BETA 0.6743 52-week High/Low 58.25 / 36.48 Profit Margin7.8888
Operating Cash Flow Growth72.366 Altman Z-Score6.8378 Free Cash Flow to Firm 22.928 Million
View SEC Filings from EGRX instead.

View recent insider trading info

Funds Holding EGRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EGRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MORAN MICHAEL SHAWN EVP, CHIEF COMMERCIAL OFFICER

  • Officer
24,268 2021-09-27 1

BORIO LUCIANA

  • Director
0 2021-04-28 2

RATOFF STEVEN B

  • Director
27,364 2021-04-08 2

TARRIFF SCOTT CEO

  • Officer
  • Director
  • 10% Owner
1,544,906 2021-04-01 2

GRAVES MICHAEL

  • Director
0 2021-02-02 1

PERNOCK DAVID PRES & CHIEF OPERATING OFFICER

  • Officer
54,625 2021-02-02 4

SIMPSON JENNIFER K.

  • Director
0 2021-02-02 1

GLENNING ROBERT

  • Director
0 2021-02-02 1

EDLIN RICHARD A.

  • Director
0 2021-02-02 1

NG-CASHIN JUDITH CHIEF MEDICAL OFFICER

  • Officer
2,000 2021-02-02 1

CAHILL BRIAN JOSEPH CHIEF FINANCIAL OFFICER

  • Officer
27,566 2021-02-02 5

MEYERS PETE A. CHIEF FINANCIAL OFFICER

  • Officer
43,615 2020-01-23 0

HEPNER ADRIAN EVP AND CHIEF MEDICAL OFFICER

  • Officer
48,784 2020-01-23 0

HUDSON EXECUTIVE CAPITAL LP

HEC MANAGEMENT GP LLC

BRAUNSTEIN DOUGLAS L

  • Director
732,777 2019-10-24 0

BRAUNSTEIN DOUGLAS L

  • Director
811,777 2019-05-09 0

FLAUM SANDER A

  • Director
13,510 2019-03-05 0

KRILL STEVEN L. EVP & CHIEF SCIENTIFIC OFFICER

  • Officer
3,000 2018-01-07 0

PROQUEST INVESTMENTS IV, L.P.

PROQUEST FINANCIAL LLC

PROQUEST ASSOCIATES IV LLC

MOORIN JAY

SCHREIBER ALAIN

  • 10% Owner
No longer subject to file 2017-05-15 0

RIGGS DAVID E CHIEF FINANCIAL OFFICER

  • Officer
0 2017-01-04 0

PROQUEST MANAGEMENT LLC

PROQUEST INVESTMENTS IV, L.P.

PROQUEST ASSOCIATES IV LLC

MOORIN JAY

SCHREIBER ALAIN

  • Director
  • 10% Owner
4,780,188 2016-05-20 0

PROQUEST FINANCIAL LLC

  • 10% Owner
4,780,188 2016-05-20 0

MOORIN JAY

  • Director
  • 10% Owner
0 2016-01-04 0

SCHREIBER ALAIN

  • Director
0 2016-01-04 0

BRUINENBERG PAUL CHIEF MEDICAL OFFICER

  • Officer
0 2014-08-26 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 22:15:03 UTC -0.3598 0.4298 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 21:45:03 UTC -0.3598 0.4298 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 21:15:03 UTC -0.3598 0.4298 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 20:45:03 UTC -0.3598 0.4298 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 20:15:03 UTC -0.3598 0.4298 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 19:45:04 UTC -0.3598 0.4298 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 19:15:03 UTC -0.3598 0.4298 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 18:45:04 UTC -0.3598 0.4298 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 18:15:04 UTC -0.3598 0.4298 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 17:45:03 UTC -0.3598 0.4298 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 17:15:03 UTC -0.3598 0.4298 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 16:45:03 UTC -0.5113 0.5813 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 16:15:03 UTC -0.5113 0.5813 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 15:45:03 UTC -0.5113 0.5813 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 15:15:02 UTC -0.5113 0.5813 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 14:45:03 UTC -0.5113 0.5813 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 14:15:03 UTC -0.5113 0.5813 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 13:45:04 UTC -0.5113 0.5813 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 13:15:03 UTC -0.5113 0.5813 950000
EAGLE PHARMACEUTICALS INC EGRX 2021-11-26 12:45:04 UTC -0.5113 0.5813 950000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund EGRX -47.0 shares, $-2162.0 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund EGRX -22.0 shares, $-1012.0 2020-03-31 N-PORT

Elevate your investments